Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys

NCT00321113 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

KIDNEY TRANSPLANTATION

Interventions

DRUG: tacrolimus
DRUG: mycophenolate mofetil
DRUG: steroids

Sponsor

Astellas Pharma Inc